$DOVA Dova Pharmaceuticals Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dova Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Dova Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Dova Pharmaceuticals Inc. for free.
IRS Number: 813858961
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: DOVA
Company Address: 240 LEIGH FARM ROAD DURHAM 27707
Phone number: 434-980-8105
Former name: Dova Pharmaceuticals, LLC
Former name: PBM AKX Holdings, LLC
Former name: Dova Pharmaceuticals, Inc., date of change: 2016-09-19
Dova Pharmaceuticals Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
| Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Option Exercise | D | 6.07 | 1,000,000 | 6,070,000 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Option Exercise | D | 6.07 | 1,000,000 | 6,070,000 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Sell | D | 0.00 | 76,647 | 0 | 0 | 76.6 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Sell | D | 0.00 | 76,647 | 0 | 0 | 76.6 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Wysenski Nancy | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Wysenski Nancy | Director | Sell | D | 0.00 | 6,274 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Stalfort Sean | Director | Sell | U | 27.50 | 635,665 | 17,480,788 | 0 | 635.7 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Option Exercise | D | 7.32 | 33,000 | 241,560 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Sell | D | 0.00 | 6,901 | 0 | 0 | 6.9 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 1,783,226 | 49,038,715 | 0 | 1.8 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 12,979,016 | 356,922,940 | 0 | 13 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Option Exercise | D | 16.08 | 10,000 | 160,800 | 0 |